Abstract
Populations are locked down during an epidemic to slow down the rate of infection so that epidemic trajectory is "flattened". This helps to keep cases at a manageable level. Given the enormous economic damage and misery caused by a lockdown, it is imperative to keep the lockdown period limited. A lockdown is useful only if it can be ensured that after the lockdown is lifted, the epidemic trajectory does not rise sharply again. We present here the results from a mathematical model of the epidemic which examines how the timing, strength and duration of the lockdown affects the post-lockdown epidemic trajectory. Our results show the following:
A early lockdown (imposed when less than 1% of the population has been infected), of any reasonable duration, cannot prevent the return of the epidemic when the lockdown is lifted. The curve starts climbing soon after lifting the lockdown and reaches a peak of the same height as the no-lockdown curve
The post-lockdown trajectory can be flattened only if the lockdown is imposed after about 10% of the population has recovered after infection.
The slope of the post-lockdown epidemic curve depends on the level of immunity built up in the population before and during the lockdown period. Application of lockdown around the inflexion point of the epidemic curve (the point of maximum slope of the curve) ensures that the post-lockdown curve is also flattened.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding for this work
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
No data is referred in the article
